arrow
T

Thomas L Holland

Duke University School of Medicine
H指数:49
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cefepime–Zidebactam for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria, Including Metallo-β-Lactamase Producers: A Phase 2, Open-Label, Single-Arm, Multicenter Study

头孢吡肟–西地巴坦用于由碳青霉烯耐药革兰阴性菌(包括金属β-内酰胺酶产生菌)引起的感染:一项2期、开放标签、单臂、多中心研究

2026-10-230
OAAI
A Qualitative Secondary Analysis of Patient Health-Related Quality of Life in Bloodstream Infections by Source: Intra-abdominal, Urinary Tract, and Acute Bacterial Skin and Skin Structure Infection

按感染来源(腹腔内、泌尿道和急性细菌性皮肤及皮肤结构感染)对血流感染患者健康相关生活质量进行定性二次分析

2025-08-151
PRE
Clinical Utility of Plasma Microbial Cell-Free DNA Sequencing Among Immunocompromised Patients With Pneumonia
2024-07-222
OAAI
Exploration of a Potential DOOR Endpoint for Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs

使用六项抗菌药物注册试验探索医院获得性细菌性肺炎和呼吸机相关细菌性肺炎的潜在DOOR终点

2024-03-250
OA
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review
2023-10-162
PRE
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study
2023-10-1027
OAAI
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
2023-09-225
OA